Medical Research
(H80)
AMYLOIDOSIS RESEARCH CONSORTIUM INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$2.9M
Total Revenue
$2.4M
Total Expenses
N/A
Net Assets
17
Employees
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$178K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $2.9M | $2.4M | N/A | — | 17 |
| 2022 | $2.3M | $2.1M | N/A | — | 17 |
| 2021 | $1.6M | $1.7M | N/A | — | 10 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.